Clinical Trial Update: Pharmacokinetic Aspects of 25-mg Estradiol Pellet in Climacteric Women [NA]

View source ↗

Summary

This completed pharmacokinetic study evaluates a 25-mg estradiol pellet in climacteric women, providing data relevant to menopause-related therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Climacteric Syndrome
• Hypoestrogenism
• Menopause

Drugs mentioned

• Estradiol pellet (25 mg) (estradiol)

Snippet

Sponsor: Science Valley Research Institute | Conditions: Climacteric Syndrome, Menopause | NA | Status: COMPLETED